Stifel Initiates Coverage On Achieve Life Sciences with Buy Rating, Announces Price Target of $18

Benzinga Newsdesk www.benzinga.com Neutral 59.3%

Neg 0% Neu 59.3% Pos 0%

Stifel analyst James Condulis initiates coverage on Achieve Life Sciences (NASDAQ:ACHV) with a Buy rating and announces Price Target of $18.